Multivariate model estimates1 for selected CD4+ T-cell subtypes vs. selected key covariates.

“Est.” = Estimate; “p” = p-value; “Week” = treatment week of the ACTG 366 clinical trial1Estimates are adjusted for gender, age group (1–5yrs, 6–12 yrs, >12 yrs), baseline ARV regimen (cART with NFV, cART without NFV, no cART), HIV-1 RNA (log10cp/ml), race/ethnicity (Hispanic, Black, White/other), viral load response at week 16 (responder, partial-responder, non-responder, missing), treatment arm (1a, 1b, 2, ¾) main effect and interaction with week, in addition to covariates listed in table.Multivariate model estimates1 for selected CD4+ T-cell subtypes vs. selected key covariates.